Publication|Articles|September 24, 2025
Supplements and Featured Publications
- Long-Acting Injectable Administration In Schizophrenia With Insights From Genoa Healthcare® Pharmacy
Long-Acting Injectable Program Implementation Insights From Genoa Healthcare® Pharmacy
Listen
0:00 / 0:00
Advertisement
This educational resource was sponsored by Johnson & Johnson.
Part 2 of this educational resource provides insights for institutions seeking to implement a pharmacist-led long-acting injectable administration program for schizophrenia.
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
RSV Vaccination Effective in Older Adults, but Protection Declines Over Time
2
Older Adults Drive Hospitalizations, Costs in the US 2024-2025 Influenza Season
3
Discontinuing GLP-1s Before or Early in Pregnancy Tied to Weight Gain, Pregnancy Complications
4
Tapinarof Shows Strong Efficacy, Sleep Benefits in Pediatric AD Across Comorbidities: Druhan Howell, MD
5










































